Dr Gabriela Staber > CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH > Vienna, Austria > Lawyer Profile

CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH
1010 WIEN
Gabriela Staber photo

Work Department

Intellectual Property, Life Sciences & Healthcare ,TMC (technology, media & telecommunications), ESG,


Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  She advises on issues related to the marketing and distribution of pharmaceuticals and medical devices as well as the protection of intellectual property. Her expertise includes advertising and product labelling, compliance, restructuring of distribution systems, reimbursement / market access, clinical trials, licensing, counterfeits and parallel imports and dispute resolution.


Her clients include pharmaceutical, medical device and biotechnology companies, healthcare start-ups and online pharmacies


English; German,


  • 2011 – Bar admission in New York and Massachusetts
  • 2010 – LL.M. in Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School (Boston)
  • 2007 – Bar admission in Austria
  • 2004 – Doctor iuris in Commercial Law (Antitrust Law), University of Vienna
  • 2001 – LL.M. in European Law, King’s College London
  • 1999 – Master of Laws, University of Vienna


Gabriela Staber regularly publishes in specialist journals. She has co-authored of commentaries on the European Union Trademark Regulation and the Community Design Regulation, as well as contributing to the publication Distribution & Marketing of Drugs. She regularly lectures and holds trainings in the abovementioned fields.


Lawyer Rankings

Austria > Intellectual property

CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH‘s ‘extremely competent’ team advises clients on all aspects of IP projects, including trade mark, copyright and patent registrations and prosecutions. The group often leverages its international network to assist clients with long-running global portfolio management, in addition to handling matters concerning trade secrets and traditional IP disputes. Practice head Egon Engin-Deniz takes a ‘direct, bold and very effective’ approach to trade mark, patent and domain issues when assisting pharmaceutical, IT and consumer clients. Gabriela Staber‘s maintains a regulatory and IP focused practice, while Hans Lederer, who was promoted to partner in February 2023, focuses on trade mark prosecution and copyright matters.